Known diagnosis of neuroendocrine tumor or suspected SSTR positive tumors by 111In-Octreotide scan, 18FDG-PET, or MRI of the abdomen where clinically indicated
At least 18 years of age
Able to provide informed consent
Karnofsky performance score greater than 50
Females of childbearing potential must have a negative pregnancy test at screening/baseline
You may not be if
Serum creatinine \> 2.0 mg/dL
Hepatic enzyme levels more than 3 times upper limit of normal
Known severe allergy or hypersensitivity to IV radiographic contrast
Use of any other investigational product or device within 30 days prior to dosing, or known requirement for any other investigational agent prior to completion of all scheduled study assessments
Patients with a body weight of 400 pounds or more or not able to enter the bore of the PET/CT scanner due to BMI, because of the compromise in image quality with CT, PET/CT, and MRI that will result
Inability to lie still for the entire imaging time (e.g. cough, severe arthritis, etc.)
Inability to complete the needed investigational standard-of-care imaging examinations due to other reasons (severe claustrophobia, radiation phobia, etc.)
Recognized concurrent active infection
Previous systemic or radiation treatment for another cancer of any type within the last 2 years
Any additional medical condition, serious intercurrent illness, or other extenuating circumstance that, in the opinion of the Investigator, may significantly interfere with study compliance
